Skip to content
Search

Latest Stories

Digital Health Academy adds new CPD-accredited module to strengthen health innovators and patients engagement

The new ‘How to Involve and Engage Patients on Digital Health Tech Innovation’ learning module has been created specifically to support the development and delivery of patient-centric technologies, at a time of critical digital transformation in the NHS.

The foundation level module will be freely available at www.orcha-digitalhealthacademy.com and on the Health Education England NHS Learning Hub (learninghub.nhs.uk).


No training previously exists on conducting effective patient and public involvement and engagement (PPIE), leading to wasted resource on unsuitable technologies at a time when the healthcare system simply cannot afford it. The module aims to educate innovators who are creating new technology, and the clinicians who are prescribing these solutions. Crucially, the module also provides valuable support to the 500 NHS clinicians who are on the Clinical Entrepreneur Programme.

The module is an introduction to the first evidence-based framework for PPIE, launched by the University of Plymouth, the AHSN Network (the national voice of the 15 academic health science networks in England) and Boehringer Ingelheim UK & Ireland. It helps to fast-track learning for the EnACT principles described in the framework, outlining how to involve patients in product innovation and critical issues such as data privacy, intellectual property, inclusivity, reimbursement, useability, and recruitment of patients.

Dr Tom Micklewright, General Practitioner and Clinical Director of Organisation for the Review of Care and Health Apps (ORCHA) spoke about the critical need for the new module, "Digital health tools have the potential to transform how frontline workers deliver healthcare, but this will only work if patients use the tools. I've seen first-hand how some health apps have lost the confidence of patients because they were never really designed with usability in mind. I hope having this module on the Academy will help clinical entrepreneurs at a practical level and will also help my colleagues on the frontline understand more about health app development."

Liz Ashall-Payne, CEO of ORCHA said, "We're very pleased to be adding this excellent module onto our Academy platform. The Academy exists to help frontline health and care workers build their digital confidence and skills, and part of this learning is an understanding of how these digital tools have been developed by clinical entrepreneurs in the first place. This highly instructive video module, which is based on an award-winning training manual, will do just that. ORCHA will also be making this module available to the digital health developer community, through a new portal."

Naj Rotheram, Medical Lead for Partnerships at Boehringer Ingelheim UK and Ireland commented, “The most effective patient resources are co-designed, so we are extremely proud to have been involved in the development of this latest module. The work conducted on the PPIE initiative reinforces Boehringer Ingelheim’s commitment to delivering patient-centric digital transformation, helping to create a more sustainable healthcare system.”

The Digital Health Academy was launched in 2022 in response to the lack of mandatory digital health training for health and care professionals. Since its launch, the ORCHA Digital Health Academy has been consistently amongst the most-accessed courses on the Health Education England Learning Hub.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less